MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fcvm.2026.1806053

Медицинская библиотека · Frontiers in cardiovascular medicine · 2026

Development and validation of a risk prediction model for myocardial hypoperfusion after primary PCI in ST-segment elevation myocardial infarction.

Zhao Yan, Fang Xiaoxia, Li Huilin, Han Minglei, Zhang Fucheng, Qiao Mingming

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To analyze the determinants of myocardial hypoperfusion following primary percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI) and to develop a risk prediction model.

METHODS

Clinical data from 434 patients with STEMI who underwent primary PCI at our hospital between January 2023 and June 2025 were retrospectively collected. Patients were randomly assigned to a training cohort (n = 304) and a validation cohort (n = 130) at a 7:3 ratio. Based on postprocedural myocardial perfusion, the training cohort was further divided into a hypoperfusion group (n = 103) and a normal perfusion group (n = 201). Candidate variables were screened using Boruta and least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable logistic regression to identify independent predictors. A risk prediction model was constructed using R software and visualized as a nomogram. Model performance and clinical utility were evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA).

RESULTS

Multivariable logistic regression identified time from onset to primary PCI, atorvastatin dose before PCI, balloon deflation method during PCI, red cell distribution width (RDW), and monoamine oxidase (MAO) levels as independent predictors of myocardial hypoperfusion (all P < 0.05). The nomogram demonstrated good discrimination, with area under the curve (AUC) values of 0.855 (95% CI: 0.811-0.900) in the training cohort and 0.838 (95% CI: 0.764-0.912) in the validation cohort. Calibration curves indicated good agreement between predicted and observed outcomes. Decision curve analysis showed that the model provided greater net benefit than both treat-all and treat-none strategies across threshold probabilities of 0.01-0.99 in the training cohort and 0.07-0.99 in the validation cohort.

CONCLUSION

Time from onset to primary PCI, atorvastatin dose before PCI, balloon deflation method during PCI, RDW, and MAO levels are important determinants of myocardial hypoperfusion following primary PCI in patients with STEMI. The proposed prediction model demonstrated favorable predictive performance and clinical utility, suggesting its potential value for early risk stratification.

Для цитирования: Zhao Yan, Fang Xiaoxia, Li Huilin, Han Minglei, Zhang Fucheng, Qiao Mingming. Development and validation of a risk prediction model for myocardial hypoperfusion after primary PCI in ST-segment elevation myocardial infarction.. Frontiers in cardiovascular medicine. 2026. DOI: 10.3389/fcvm.2026.1806053.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.